Chardan Capital Initiates Signal Genetics At Buy

Loading...
Loading...
Analysts at Chardan Capital initiated coverage on
Signal Genetics IncSGNL
with a Buy rating. The target price for Signal Genetics is set to $2.50. Signal Genetics shares have dropped 80.76 percent over the past 52 weeks, while the S&P 500 index has surged 8.87 percent in the same period. Signal Genetics' shares rose 1.32 percent to close at $1.53 yesterday.
Posted In: InitiationAnalyst RatingsChardan Capital
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...